Page last updated: 2024-09-03

3,3'-dipropyl-2,2'-thiadicarbocyanine and mitomycin

3,3'-dipropyl-2,2'-thiadicarbocyanine has been researched along with mitomycin in 1 studies

Compound Research Comparison

Studies
(3,3'-dipropyl-2,2'-thiadicarbocyanine)
Trials
(3,3'-dipropyl-2,2'-thiadicarbocyanine)
Recent Studies (post-2010)
(3,3'-dipropyl-2,2'-thiadicarbocyanine)
Studies
(mitomycin)
Trials
(mitomycin)
Recent Studies (post-2010) (mitomycin)
13401212,8931,7382,808

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuchimoto, S; Iwagaki, H; Miyake, M; Orita, K; Shiiki, S1

Other Studies

1 other study(ies) available for 3,3'-dipropyl-2,2'-thiadicarbocyanine and mitomycin

ArticleYear
Monitoring the effect of an anti-cancer drug on RPMI 4788 cells by a membrane potential probe, dis-C3-(5).
    Journal of medicine, 1989, Volume: 20, Issue:2

    Topics: Antineoplastic Agents; Benzothiazoles; Carbocyanines; Cell Line; Colonic Neoplasms; Fluorescent Dyes; Humans; Membrane Potentials; Mitomycin; Mitomycins

1989